Le Lézard
Classified in: Business, Covid-19 virus
Subject: VEN

Fincasa Announces Global Online Investment Summit "Next Generation Visionaries"


DUBAI, United Arab Emirates, July 5, 2020 /CNW/ -- FINCASA VENTURES, UAE-based venture capital and advisor to Multi-Royal-Family Fund Houses, announces Investment summit with objective to syndicate USD 1.0 Bn investment in potential companies and start-ups during and post COVID-19 through its stellar consortium of international and domestic investors led by Family Offices, Angels, Funds.

FINCASA ANNOUNCES GLOBAL ONLINE INVESTMENT SUMMIT "NEXT GENERATION VISIONARIES"

This summit invites top industry experts/speakers/panelists and investors from all over the globe with the purpose to identify potential start-ups for investments.

It will be live streaming via major social media channels, organized in association with Strategic Swiss Partners (SSP), Switzerland and JW-Prime Management Consultancy, Philippines.

Fincasa Ventures is a promising global venture capital led by Founder and Group CEO Varis Sayed, Entrepreneur, Co-Founder and Mentor for various companies globally ? from start-ups to private equity. He is specializing in cross border international businesses and investments.

Fincasa Ventures recent investment announcement:

Varis Sayed affirmed that he has invested 50 million USD in MediSponsor.Inc - USA incorporated company, which offers easy-to-use XAAS-based innovative yet Integrated Healthcare Cloud CRM Solution along with Payment Gateway.

MediSponsor is a camel of health-tech industry for investors. It will bring value proposition on COVID-19 Pandemic through its Visual Analytics technology as well as impact in healthcare service delivery. Fincasa invites global investors for second round of funding to align Phase II R&D plans.

Varis Sayed informed that Rahul Pawar, Founder & CEO of MediSponsor, was appointed as Advisory ? Head Global Start-up Hub in Fincasa Ventures to shortlist start-ups across the globe for investments. Due to his ideation and solution architecting capabilities Varis Sayed is calling Rahul Pawar as Steve Jobs from India and supports his vision for MediSponsor - from Navi Mumbai to NASDAQ.

Recent investment by Fincasa would enable MediSponsor to capitalize and position a company in the healthcare sector of Africa, Middle East, South America & South Asia through care model innovation and digital market transformation.

L-R - Dr. Nilesh Patil, Varis Sayed, Rahul Pawar, Dr. Roshan Patil

MediSponsor leadership team includes "A perfect blend of Healthcare & Management domain" - co-founders Dr. Roshan Patil and Dr. Nilesh Patil from the Indian Institutes of Management, which is ranked among the best globally for its various management programs.

MediSponsor Head Quarters in Dubai, UAE gives the company a world-class business environment for speedy growth. Fincasa investment along with strategic partnership will help MediSponsor to achieve its vision of being the most valued brand in Healthcare Technology.

SOURCE Fincasa Ventures


These press releases may also interest you

at 16:10
Flux Power Holdings, Inc. , a developer of advanced lithium-ion energy storage solutions for electrification of commercial and industrial equipment, today announced the appointment of Mark Leposky, a senior-level executive and entrepreneur, to its...

at 16:10
PPG today reported financial results for the first quarter 2024. First Quarter Consolidated Results $ in millions, except EPS 1Q 2024 1Q 2023 YOY change Net sales $4,311 $4,380 (2)% Net...

at 16:10
Metropolitan Bank Holding Corp. (the "Company") , the holding company for Metropolitan Commercial Bank (the "Bank"), reported net income of $16.2 million, or $1.46 per diluted common share, for the first quarter of 2024 compared to $14.6 million, or...

at 16:05
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced its revenue guidance for the second quarter of 2024. The company expects to report revenue in the...

at 16:00
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a specialty pharmaceutical company, today announced receipt of a Complete Response Letter ("CRL") for its Priority Original Abbreviated New Drug Application ("ANDA") for Ketamine that was...

at 15:25
Corbin Advisors, a strategic consultancy accelerating value realization globally, today released its quarterly Earnings Primer®, which captures trends in institutional investor sentiment. The survey, which marks the 58th issue of Inside The Buy-Side®...



News published on and distributed by: